KPIs & Operating Metrics(New)
Growth Metrics

Abbott Laboratories (ABT) Gross Profit (2016 - 2026)

Abbott Laboratories' Gross Profit history spans 18 years, with the latest figure at $6.3 billion for Q1 2026.

  • On a quarterly basis, Gross Profit rose 6.52% to $6.3 billion in Q1 2026 year-over-year; TTM through Mar 2026 was $25.4 billion, a 7.45% increase, with the full-year FY2025 number at $25.0 billion, up 7.59% from a year prior.
  • Gross Profit hit $6.3 billion in Q1 2026 for Abbott Laboratories, down from $6.5 billion in the prior quarter.
  • Over the last five years, Gross Profit for ABT hit a ceiling of $6.9 billion in Q1 2022 and a floor of $5.4 billion in Q1 2023.
  • Historically, Gross Profit has averaged $6.0 billion across 5 years, with a median of $5.9 billion in 2025.
  • Biggest five-year swings in Gross Profit: increased 19.86% in 2022 and later decreased 21.6% in 2023.
  • Tracing ABT's Gross Profit over 5 years: stood at $5.5 billion in 2022, then increased by 3.4% to $5.7 billion in 2023, then rose by 6.1% to $6.0 billion in 2024, then grew by 8.37% to $6.5 billion in 2025, then decreased by 4.02% to $6.3 billion in 2026.
  • Business Quant data shows Gross Profit for ABT at $6.3 billion in Q1 2026, $6.5 billion in Q4 2025, and $6.3 billion in Q3 2025.